IL99507A - הכנת אימונוגלובולינים בעלי ספציפיותלאנטיגן ידוע בתא פונדקאי מותמר, וקטורים ותאים מותמרים המשתמשים לכך - Google Patents

הכנת אימונוגלובולינים בעלי ספציפיותלאנטיגן ידוע בתא פונדקאי מותמר, וקטורים ותאים מותמרים המשתמשים לכך

Info

Publication number: IL99507A
Authority: IL; Israel
Prior art keywords: host cell; dna; heavy; fragment; chain
Prior art date: 1983-04-08

Application number

IL9950784A

Other languages

English (en)

Original Assignee

Genentech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1983-04-08

Filing date

1984-04-06

Publication date

1995-03-30

1983-04-08 Priority claimed from US06/483,457 external-priority patent/US4816567A/en

1984-04-06 Application filed by Genentech Inc filed Critical Genentech Inc

1995-03-30 Publication of IL99507A publication Critical patent/IL99507A/he

Links

239000013598 vector Substances 0.000 title claims description 55
239000000427 antigen Substances 0.000 title claims description 40
102000036639 antigens Human genes 0.000 title claims description 40
108091007433 antigens Proteins 0.000 title claims description 40
108060003951 Immunoglobulin Proteins 0.000 title claims description 34
102000018358 immunoglobulin Human genes 0.000 title claims description 34
238000002360 preparation method Methods 0.000 title description 15
238000000034 method Methods 0.000 claims description 92
239000013612 plasmid Substances 0.000 claims description 65
108091028043 Nucleic acid sequence Proteins 0.000 claims description 48
230000008569 process Effects 0.000 claims description 28
240000004808 Saccharomyces cerevisiae Species 0.000 claims description 11
241000588724 Escherichia coli Species 0.000 claims description 9
241000894006 Bacteria Species 0.000 claims description 5
102000008394 Immunoglobulin Fragments Human genes 0.000 claims description 5
108010021625 Immunoglobulin Fragments Proteins 0.000 claims description 5
230000001131 transforming effect Effects 0.000 claims description 5
239000012528 membrane Substances 0.000 claims description 3
235000014469 Bacillus subtilis Nutrition 0.000 claims description 2
238000003780 insertion Methods 0.000 claims description 2
230000037431 insertion Effects 0.000 claims description 2
210000000481 breast Anatomy 0.000 claims 1
239000012634 fragment Substances 0.000 description 116
210000004027 cell Anatomy 0.000 description 107
108090000623 proteins and genes Proteins 0.000 description 97
108020004414 DNA Proteins 0.000 description 57
230000002494 anti-cea effect Effects 0.000 description 44
235000018102 proteins Nutrition 0.000 description 43
102000004169 proteins and genes Human genes 0.000 description 43
238000010276 construction Methods 0.000 description 33
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 28
239000002299 complementary DNA Substances 0.000 description 27
210000004408 hybridoma Anatomy 0.000 description 27
239000013604 expression vector Substances 0.000 description 22
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 20
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 20
235000001014 amino acid Nutrition 0.000 description 20
150000001413 amino acids Chemical class 0.000 description 20
125000003275 alpha amino acid group Chemical group 0.000 description 19
239000002773 nucleotide Substances 0.000 description 19
125000003729 nucleotide group Chemical group 0.000 description 19
229940072221 immunoglobulins Drugs 0.000 description 18
238000004519 manufacturing process Methods 0.000 description 18
210000003719 b-lymphocyte Anatomy 0.000 description 17
108091008146 restriction endonucleases Proteins 0.000 description 17
239000000523 sample Substances 0.000 description 17
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 16
238000006243 chemical reaction Methods 0.000 description 16
239000004098 Tetracycline Substances 0.000 description 15
229960002180 tetracycline Drugs 0.000 description 15
229930101283 tetracycline Natural products 0.000 description 15
235000019364 tetracycline Nutrition 0.000 description 15
150000003522 tetracyclines Chemical class 0.000 description 15
238000007792 addition Methods 0.000 description 14
238000004113 cell culture Methods 0.000 description 14
230000029087 digestion Effects 0.000 description 13
239000000499 gel Substances 0.000 description 13
108090000765 processed proteins & peptides Proteins 0.000 description 13
108010022366 Carcinoembryonic Antigen Proteins 0.000 description 12
102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 description 12
108091026890 Coding region Proteins 0.000 description 12
241001529936 Murinae Species 0.000 description 12
239000000203 mixture Substances 0.000 description 12
239000013615 primer Substances 0.000 description 12
102000004196 processed proteins & peptides Human genes 0.000 description 12
230000004044 response Effects 0.000 description 12
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 11
238000002955 isolation Methods 0.000 description 11
239000002953 phosphate buffered saline Substances 0.000 description 11
210000001519 tissue Anatomy 0.000 description 11
235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 10
108020004999 messenger RNA Proteins 0.000 description 10
229920002401 polyacrylamide Polymers 0.000 description 10
229920001184 polypeptide Polymers 0.000 description 10
239000011780 sodium chloride Substances 0.000 description 10
102000004594 DNA Polymerase I Human genes 0.000 description 9
108010017826 DNA Polymerase I Proteins 0.000 description 9
239000007983 Tris buffer Substances 0.000 description 9
241000251539 Vertebrata <Metazoa> Species 0.000 description 9
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 9
229960000723 ampicillin Drugs 0.000 description 9
230000000295 complement effect Effects 0.000 description 9
230000000694 effects Effects 0.000 description 9
150000007523 nucleic acids Chemical group 0.000 description 9
238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 9
239000000243 solution Substances 0.000 description 9
241000894007 species Species 0.000 description 9
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 9
SXOUIMVOMIGLHO-AATRIKPKSA-N (E)-3-(indol-2-yl)acrylic acid Chemical compound C1=CC=C2NC(/C=C/C(=O)O)=CC2=C1 SXOUIMVOMIGLHO-AATRIKPKSA-N 0.000 description 8
238000001502 gel electrophoresis Methods 0.000 description 8
230000012010 growth Effects 0.000 description 8
PLVPPLCLBIEYEA-UHFFFAOYSA-N indoleacrylic acid Natural products C1=CC=C2C(C=CC(=O)O)=CNC2=C1 PLVPPLCLBIEYEA-UHFFFAOYSA-N 0.000 description 8
230000004048 modification Effects 0.000 description 8
238000012986 modification Methods 0.000 description 8
YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 8
239000000047 product Substances 0.000 description 8
239000011541 reaction mixture Substances 0.000 description 8
230000010076 replication Effects 0.000 description 8
108020004705 Codon Proteins 0.000 description 7
102000004190 Enzymes Human genes 0.000 description 7
108090000790 Enzymes Proteins 0.000 description 7
206010028980 Neoplasm Diseases 0.000 description 7
101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 7
230000000890 antigenic effect Effects 0.000 description 7
239000000872 buffer Substances 0.000 description 7
210000004899 c-terminal region Anatomy 0.000 description 7
239000002131 composite material Substances 0.000 description 7
238000005516 engineering process Methods 0.000 description 7
229940088598 enzyme Drugs 0.000 description 7
239000013613 expression plasmid Substances 0.000 description 7
238000011065 in-situ storage Methods 0.000 description 7
108020004707 nucleic acids Proteins 0.000 description 7
102000039446 nucleic acids Human genes 0.000 description 7
230000008439 repair process Effects 0.000 description 7
241000829100 Macaca mulatta polyomavirus 1 Species 0.000 description 6
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 6
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
238000004458 analytical method Methods 0.000 description 6
238000003776 cleavage reaction Methods 0.000 description 6
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
230000003278 mimic effect Effects 0.000 description 6
238000010188 recombinant method Methods 0.000 description 6
239000000126 substance Substances 0.000 description 6
230000009466 transformation Effects 0.000 description 6
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 5
102000012410 DNA Ligases Human genes 0.000 description 5
108010061982 DNA Ligases Proteins 0.000 description 5
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 5
108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 5
241000124008 Mammalia Species 0.000 description 5
206010035226 Plasma cell myeloma Diseases 0.000 description 5
108020004511 Recombinant DNA Proteins 0.000 description 5
230000002776 aggregation Effects 0.000 description 5
238000004220 aggregation Methods 0.000 description 5
238000000429 assembly Methods 0.000 description 5
230000000712 assembly Effects 0.000 description 5
230000008901 benefit Effects 0.000 description 5
230000015572 biosynthetic process Effects 0.000 description 5
238000005119 centrifugation Methods 0.000 description 5
238000010367 cloning Methods 0.000 description 5
239000000284 extract Substances 0.000 description 5
238000000605 extraction Methods 0.000 description 5
238000000338 in vitro Methods 0.000 description 5
238000011534 incubation Methods 0.000 description 5
239000000543 intermediate Substances 0.000 description 5
239000000463 material Substances 0.000 description 5
230000000813 microbial effect Effects 0.000 description 5
239000013600 plasmid vector Substances 0.000 description 5
238000011084 recovery Methods 0.000 description 5
230000007017 scission Effects 0.000 description 5
238000001262 western blot Methods 0.000 description 5
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 4
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 4
102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 4
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 4
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 4
102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 4
108091081024 Start codon Proteins 0.000 description 4
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 4
230000001580 bacterial effect Effects 0.000 description 4
238000012217 deletion Methods 0.000 description 4
230000037430 deletion Effects 0.000 description 4
238000001962 electrophoresis Methods 0.000 description 4
230000006870 function Effects 0.000 description 4
230000004927 fusion Effects 0.000 description 4
230000002068 genetic effect Effects 0.000 description 4
210000004962 mammalian cell Anatomy 0.000 description 4
201000000050 myeloid neoplasm Diseases 0.000 description 4
230000017854 proteolysis Effects 0.000 description 4
230000002829 reductive effect Effects 0.000 description 4
238000010561 standard procedure Methods 0.000 description 4
230000003612 virological effect Effects 0.000 description 4
108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
102000002260 Alkaline Phosphatase Human genes 0.000 description 3
108020004774 Alkaline Phosphatase Proteins 0.000 description 3
108020001019 DNA Primers Proteins 0.000 description 3
239000003155 DNA primer Substances 0.000 description 3
BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 3
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
238000002965 ELISA Methods 0.000 description 3
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
102000004877 Insulin Human genes 0.000 description 3
108090001061 Insulin Proteins 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
230000004075 alteration Effects 0.000 description 3
238000003556 assay Methods 0.000 description 3
239000004202 carbamide Substances 0.000 description 3
239000013599 cloning vector Substances 0.000 description 3
235000018417 cysteine Nutrition 0.000 description 3
125000000151 cysteine group Chemical class N[C@@H](CS)C(=O)* 0.000 description 3
238000000502 dialysis Methods 0.000 description 3
150000002019 disulfides Chemical class 0.000 description 3
239000012636 effector Substances 0.000 description 3
238000012869 ethanol precipitation Methods 0.000 description 3
238000002474 experimental method Methods 0.000 description 3
238000010353 genetic engineering Methods 0.000 description 3
239000008103 glucose Substances 0.000 description 3
229940125396 insulin Drugs 0.000 description 3
210000003519 mature b lymphocyte Anatomy 0.000 description 3
244000005700 microbiome Species 0.000 description 3
238000002156 mixing Methods 0.000 description 3
230000001590 oxidative effect Effects 0.000 description 3
239000008188 pellet Substances 0.000 description 3
238000001556 precipitation Methods 0.000 description 3
238000000746 purification Methods 0.000 description 3
238000005215 recombination Methods 0.000 description 3
230000006798 recombination Effects 0.000 description 3
238000011160 research Methods 0.000 description 3
229920006395 saturated elastomer Polymers 0.000 description 3
229910052709 silver Inorganic materials 0.000 description 3
239000000758 substrate Substances 0.000 description 3
238000013518 transcription Methods 0.000 description 3
230000035897 transcription Effects 0.000 description 3
230000014616 translation Effects 0.000 description 3
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 3
HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
OSJPPGNTCRNQQC-UWTATZPHSA-N 3-phospho-D-glyceric acid Chemical compound OC(=O)[C@H](O)COP(O)(O)=O OSJPPGNTCRNQQC-UWTATZPHSA-N 0.000 description 2
HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
229920001817 Agar Polymers 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
241001646716 Escherichia coli K-12 Species 0.000 description 2
102000012745 Immunoglobulin Subunits Human genes 0.000 description 2
108010079585 Immunoglobulin Subunits Proteins 0.000 description 2
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 2
239000000020 Nitrocellulose Substances 0.000 description 2
241000283973 Oryctolagus cuniculus Species 0.000 description 2
229910019142 PO4 Inorganic materials 0.000 description 2
241001494479 Pecora Species 0.000 description 2
108091036066 Three prime untranslated region Proteins 0.000 description 2
229940117913 acrylamide Drugs 0.000 description 2
239000008272 agar Substances 0.000 description 2
238000003277 amino acid sequence analysis Methods 0.000 description 2
101150073130 ampR gene Proteins 0.000 description 2
238000006664 bond formation reaction Methods 0.000 description 2
OSQPUMRCKZAIOZ-UHFFFAOYSA-N carbon dioxide;ethanol Chemical compound CCO.O=C=O OSQPUMRCKZAIOZ-UHFFFAOYSA-N 0.000 description 2
210000002421 cell wall Anatomy 0.000 description 2
230000036755 cellular response Effects 0.000 description 2
239000001913 cellulose Substances 0.000 description 2
229920002678 cellulose Polymers 0.000 description 2
238000012512 characterization method Methods 0.000 description 2
238000004587 chromatography analysis Methods 0.000 description 2
230000009089 cytolysis Effects 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
238000013461 design Methods 0.000 description 2
238000001514 detection method Methods 0.000 description 2
239000005546 dideoxynucleotide Substances 0.000 description 2
201000010099 disease Diseases 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
238000011049 filling Methods 0.000 description 2
108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 2
102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 2
PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 2
208000006454 hepatitis Diseases 0.000 description 2
238000009396 hybridization Methods 0.000 description 2
230000028993 immune response Effects 0.000 description 2
210000000987 immune system Anatomy 0.000 description 2
230000016784 immunoglobulin production Effects 0.000 description 2
230000001771 impaired effect Effects 0.000 description 2
238000005304 joining Methods 0.000 description 2
239000006166 lysate Substances 0.000 description 2
229910001629 magnesium chloride Inorganic materials 0.000 description 2
239000003550 marker Substances 0.000 description 2
210000004379 membrane Anatomy 0.000 description 2
229930182817 methionine Natural products 0.000 description 2
238000002703 mutagenesis Methods 0.000 description 2
231100000350 mutagenesis Toxicity 0.000 description 2
229920001220 nitrocellulos Polymers 0.000 description 2
108091027963 non-coding RNA Proteins 0.000 description 2
102000042567 non-coding RNA Human genes 0.000 description 2
239000010452 phosphate Substances 0.000 description 2
230000008488 polyadenylation Effects 0.000 description 2
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
230000009467 reduction Effects 0.000 description 2
238000012552 review Methods 0.000 description 2
238000012216 screening Methods 0.000 description 2
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
239000006228 supernatant Substances 0.000 description 2
238000003786 synthesis reaction Methods 0.000 description 2
238000001890 transfection Methods 0.000 description 2
238000013519 translation Methods 0.000 description 2
210000004881 tumor cell Anatomy 0.000 description 2
238000005406 washing Methods 0.000 description 2
NWXMGUDVXFXRIG-WESIUVDSSA-N (4s,4as,5as,6s,12ar)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O NWXMGUDVXFXRIG-WESIUVDSSA-N 0.000 description 1
101150084750 1 gene Proteins 0.000 description 1
GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
XXMFJKNOJSDQBM-UHFFFAOYSA-N 2,2,2-trifluoroacetic acid;hydrate Chemical compound [OH3+].[O-]C(=O)C(F)(F)F XXMFJKNOJSDQBM-UHFFFAOYSA-N 0.000 description 1
XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl Phosphate Chemical compound OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 description 1
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 1
102000013563 Acid Phosphatase Human genes 0.000 description 1
108010051457 Acid Phosphatase Proteins 0.000 description 1
101710187573 Alcohol dehydrogenase 2 Proteins 0.000 description 1
101710133776 Alcohol dehydrogenase class-3 Proteins 0.000 description 1
101001116457 Arabidopsis thaliana Peroxidase 47 Proteins 0.000 description 1
208000002109 Argyria Diseases 0.000 description 1
241000304886 Bacilli Species 0.000 description 1
241000193830 Bacillus <bacterium> Species 0.000 description 1
125000001433 C-terminal amino-acid group Chemical group 0.000 description 1
101100290380 Caenorhabditis elegans cel-1 gene Proteins 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
241000699802 Cricetulus griseus Species 0.000 description 1
102000053602 DNA Human genes 0.000 description 1
238000012270 DNA recombination Methods 0.000 description 1
238000012286 ELISA Assay Methods 0.000 description 1
241000588921 Enterobacteriaceae Species 0.000 description 1
241001524679 Escherichia virus M13 Species 0.000 description 1
241000192125 Firmicutes Species 0.000 description 1
210000000712 G cell Anatomy 0.000 description 1
108700039691 Genetic Promoter Regions Proteins 0.000 description 1
108700007698 Genetic Terminator Regions Proteins 0.000 description 1
102000006395 Globulins Human genes 0.000 description 1
108010044091 Globulins Proteins 0.000 description 1
102000030595 Glucokinase Human genes 0.000 description 1
108010021582 Glucokinase Proteins 0.000 description 1
102000005731 Glucose-6-phosphate isomerase Human genes 0.000 description 1
108010070600 Glucose-6-phosphate isomerase Proteins 0.000 description 1
108010024636 Glutathione Proteins 0.000 description 1
108010053070 Glutathione Disulfide Proteins 0.000 description 1
102000003886 Glycoproteins Human genes 0.000 description 1
108090000288 Glycoproteins Proteins 0.000 description 1
102000005548 Hexokinase Human genes 0.000 description 1
108700040460 Hexokinases Proteins 0.000 description 1
241000701109 Human adenovirus 2 Species 0.000 description 1
102000004195 Isomerases Human genes 0.000 description 1
108090000769 Isomerases Proteins 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
QTZXSYBVOSXBEJ-WDSKDSINSA-N Met-Asp Chemical compound CSCC[C@H](N)C(=O)N[C@H](C(O)=O)CC(O)=O QTZXSYBVOSXBEJ-WDSKDSINSA-N 0.000 description 1
241001314546 Microtis <orchid> Species 0.000 description 1
208000034578 Multiple myelomas Diseases 0.000 description 1
101100073930 Mus musculus Prkce gene Proteins 0.000 description 1
108010087702 Penicillinase Proteins 0.000 description 1
102000035195 Peptidases Human genes 0.000 description 1
108091005804 Peptidases Proteins 0.000 description 1
108010069341 Phosphofructokinases Proteins 0.000 description 1
102000001105 Phosphofructokinases Human genes 0.000 description 1
102000012288 Phosphopyruvate Hydratase Human genes 0.000 description 1
108010022181 Phosphopyruvate Hydratase Proteins 0.000 description 1
108091000080 Phosphotransferase Proteins 0.000 description 1
241000276498 Pollachius virens Species 0.000 description 1
108010076504 Protein Sorting Signals Proteins 0.000 description 1
241000589516 Pseudomonas Species 0.000 description 1
108010011939 Pyruvate Decarboxylase Proteins 0.000 description 1
102000013009 Pyruvate Kinase Human genes 0.000 description 1
108020005115 Pyruvate Kinase Proteins 0.000 description 1
108020005067 RNA Splice Sites Proteins 0.000 description 1
238000002123 RNA extraction Methods 0.000 description 1
239000012722 SDS sample buffer Substances 0.000 description 1
241000235070 Saccharomyces Species 0.000 description 1
241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
238000012300 Sequence Analysis Methods 0.000 description 1
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
108020004682 Single-Stranded DNA Proteins 0.000 description 1
LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
108020005038 Terminator Codon Proteins 0.000 description 1
102000004357 Transferases Human genes 0.000 description 1
108090000992 Transferases Proteins 0.000 description 1
102000005924 Triose-Phosphate Isomerase Human genes 0.000 description 1
108700015934 Triose-phosphate isomerases Proteins 0.000 description 1
239000007984 Tris EDTA buffer Substances 0.000 description 1
108020005202 Viral DNA Proteins 0.000 description 1
241000700605 Viruses Species 0.000 description 1
239000002253 acid Substances 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
230000004913 activation Effects 0.000 description 1
125000005037 alkyl phenyl group Chemical group 0.000 description 1
WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
125000000539 amino acid group Chemical group 0.000 description 1
208000007502 anemia Diseases 0.000 description 1
238000000137 annealing Methods 0.000 description 1
238000013459 approach Methods 0.000 description 1
239000012223 aqueous fraction Substances 0.000 description 1
239000008346 aqueous phase Substances 0.000 description 1
230000004888 barrier function Effects 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
230000000975 bioactive effect Effects 0.000 description 1
239000007853 buffer solution Substances 0.000 description 1
239000007975 buffered saline Substances 0.000 description 1
239000006227 byproduct Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
239000011575 calcium Substances 0.000 description 1
239000001110 calcium chloride Substances 0.000 description 1
229910001628 calcium chloride Inorganic materials 0.000 description 1
239000001506 calcium phosphate Substances 0.000 description 1
229910000389 calcium phosphate Inorganic materials 0.000 description 1
235000011010 calcium phosphates Nutrition 0.000 description 1
201000011510 cancer Diseases 0.000 description 1
229960004424 carbon dioxide Drugs 0.000 description 1
235000011089 carbon dioxide Nutrition 0.000 description 1
239000000969 carrier Substances 0.000 description 1
239000013592 cell lysate Substances 0.000 description 1
230000006037 cell lysis Effects 0.000 description 1
239000008004 cell lysis buffer Substances 0.000 description 1
230000036978 cell physiology Effects 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
230000033077 cellular process Effects 0.000 description 1
230000008859 change Effects 0.000 description 1
238000007385 chemical modification Methods 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
239000003638 chemical reducing agent Substances 0.000 description 1
229960005091 chloramphenicol Drugs 0.000 description 1
WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
YTRQFSDWAXHJCC-UHFFFAOYSA-N chloroform;phenol Chemical compound ClC(Cl)Cl.OC1=CC=CC=C1 YTRQFSDWAXHJCC-UHFFFAOYSA-N 0.000 description 1
239000013611 chromosomal DNA Substances 0.000 description 1
230000002759 chromosomal effect Effects 0.000 description 1
210000000349 chromosome Anatomy 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
210000000805 cytoplasm Anatomy 0.000 description 1
230000002950 deficient Effects 0.000 description 1
230000003413 degradative effect Effects 0.000 description 1
239000003398 denaturant Substances 0.000 description 1
238000009795 derivation Methods 0.000 description 1
239000003599 detergent Substances 0.000 description 1
238000011161 development Methods 0.000 description 1
238000003745 diagnosis Methods 0.000 description 1
238000002405 diagnostic procedure Methods 0.000 description 1
239000000385 dialysis solution Substances 0.000 description 1
230000004069 differentiation Effects 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
239000000539 dimer Substances 0.000 description 1
230000003292 diminished effect Effects 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
NTNZTEQNFHNYBC-UHFFFAOYSA-N ethyl 2-aminoacetate Chemical compound CCOC(=O)CN NTNZTEQNFHNYBC-UHFFFAOYSA-N 0.000 description 1
238000000855 fermentation Methods 0.000 description 1
230000004151 fermentation Effects 0.000 description 1
238000007667 floating Methods 0.000 description 1
229930182830 galactose Natural products 0.000 description 1
229960003082 galactose Drugs 0.000 description 1
238000012239 gene modification Methods 0.000 description 1
RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 1
YPZRWBKMTBYPTK-BJDJZHNGSA-N glutathione disulfide Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)NCC(O)=O)CSSC[C@@H](C(=O)NCC(O)=O)NC(=O)CC[C@H](N)C(O)=O YPZRWBKMTBYPTK-BJDJZHNGSA-N 0.000 description 1
235000013905 glycine and its sodium salt Nutrition 0.000 description 1
239000004247 glycine and its sodium salt Substances 0.000 description 1
230000002414 glycolytic effect Effects 0.000 description 1
230000013595 glycosylation Effects 0.000 description 1
238000006206 glycosylation reaction Methods 0.000 description 1
229960004198 guanidine Drugs 0.000 description 1
229960000789 guanidine hydrochloride Drugs 0.000 description 1
238000003306 harvesting Methods 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
229910001385 heavy metal Inorganic materials 0.000 description 1
231100000283 hepatitis Toxicity 0.000 description 1
210000005260 human cell Anatomy 0.000 description 1
210000004754 hybrid cell Anatomy 0.000 description 1
238000003384 imaging method Methods 0.000 description 1
210000003297 immature b lymphocyte Anatomy 0.000 description 1
230000002621 immunoprecipitating effect Effects 0.000 description 1
230000006872 improvement Effects 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
230000002779 inactivation Effects 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
239000007924 injection Substances 0.000 description 1
238000002347 injection Methods 0.000 description 1
230000003993 interaction Effects 0.000 description 1
230000009545 invasion Effects 0.000 description 1
-1 isocytochrome C Proteins 0.000 description 1
238000002372 labelling Methods 0.000 description 1
239000008101 lactose Substances 0.000 description 1
230000003902 lesion Effects 0.000 description 1
238000007169 ligase reaction Methods 0.000 description 1
239000007788 liquid Substances 0.000 description 1
210000002751 lymph Anatomy 0.000 description 1
210000004698 lymphocyte Anatomy 0.000 description 1
235000018977 lysine Nutrition 0.000 description 1
150000002669 lysines Chemical class 0.000 description 1
239000012139 lysis buffer Substances 0.000 description 1
210000002540 macrophage Anatomy 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
229940126619 mouse monoclonal antibody Drugs 0.000 description 1
210000004897 n-terminal region Anatomy 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
210000004940 nucleus Anatomy 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
210000001672 ovary Anatomy 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
YPZRWBKMTBYPTK-UHFFFAOYSA-N oxidized gamma-L-glutamyl-L-cysteinylglycine Natural products OC(=O)C(N)CCC(=O)NC(C(=O)NCC(O)=O)CSSCC(C(=O)NCC(O)=O)NC(=O)CCC(N)C(O)=O YPZRWBKMTBYPTK-UHFFFAOYSA-N 0.000 description 1
239000002245 particle Substances 0.000 description 1
230000037361 pathway Effects 0.000 description 1
229950009506 penicillinase Drugs 0.000 description 1
238000010647 peptide synthesis reaction Methods 0.000 description 1
210000001322 periplasm Anatomy 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
LFGREXWGYUGZLY-UHFFFAOYSA-N phosphoryl Chemical group [P]=O LFGREXWGYUGZLY-UHFFFAOYSA-N 0.000 description 1
230000026731 phosphorylation Effects 0.000 description 1
238000006366 phosphorylation reaction Methods 0.000 description 1
102000020233 phosphotransferase Human genes 0.000 description 1
210000004180 plasmocyte Anatomy 0.000 description 1
230000004481 post-translational protein modification Effects 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
230000002028 premature Effects 0.000 description 1
238000004321 preservation Methods 0.000 description 1
238000012545 processing Methods 0.000 description 1
210000001236 prokaryotic cell Anatomy 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
230000009145 protein modification Effects 0.000 description 1
229940116540 protein supplement Drugs 0.000 description 1
235000005974 protein supplement Nutrition 0.000 description 1
229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
210000001938 protoplast Anatomy 0.000 description 1
238000012207 quantitative assay Methods 0.000 description 1
230000002285 radioactive effect Effects 0.000 description 1
238000006894 reductive elimination reaction Methods 0.000 description 1
238000010405 reoxidation reaction Methods 0.000 description 1
238000009256 replacement therapy Methods 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
238000013341 scale-up Methods 0.000 description 1
238000000926 separation method Methods 0.000 description 1
239000004332 silver Substances 0.000 description 1
238000002741 site-directed mutagenesis Methods 0.000 description 1
238000004513 sizing Methods 0.000 description 1
FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
229940029258 sodium glycinate Drugs 0.000 description 1
239000001488 sodium phosphate Substances 0.000 description 1
229910000162 sodium phosphate Inorganic materials 0.000 description 1
229940048086 sodium pyrophosphate Drugs 0.000 description 1
HAEPBEMBOAIUPN-UHFFFAOYSA-L sodium tetrathionate Chemical compound O.O.[Na+].[Na+].[O-]S(=O)(=O)SSS([O-])(=O)=O HAEPBEMBOAIUPN-UHFFFAOYSA-L 0.000 description 1
WUWHFEHKUQVYLF-UHFFFAOYSA-M sodium;2-aminoacetate Chemical compound [Na+].NCC([O-])=O WUWHFEHKUQVYLF-UHFFFAOYSA-M 0.000 description 1
239000007787 solid Substances 0.000 description 1
238000005063 solubilization Methods 0.000 description 1
230000007928 solubilization Effects 0.000 description 1
238000000527 sonication Methods 0.000 description 1
229940043517 specific immunoglobulins Drugs 0.000 description 1
238000001228 spectrum Methods 0.000 description 1
210000004988 splenocyte Anatomy 0.000 description 1
239000007858 starting material Substances 0.000 description 1
230000000638 stimulation Effects 0.000 description 1
238000003860 storage Methods 0.000 description 1
239000000725 suspension Substances 0.000 description 1
230000008685 targeting Effects 0.000 description 1
235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
150000003573 thiols Chemical class 0.000 description 1
231100000167 toxic agent Toxicity 0.000 description 1
239000003440 toxic substance Substances 0.000 description 1
230000005030 transcription termination Effects 0.000 description 1
238000012546 transfer Methods 0.000 description 1
VLCQZHSMCYCDJL-UHFFFAOYSA-N tribenuron methyl Chemical compound COC(=O)C1=CC=CC=C1S(=O)(=O)NC(=O)N(C)C1=NC(C)=NC(OC)=N1 VLCQZHSMCYCDJL-UHFFFAOYSA-N 0.000 description 1
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
101150108727 trpl gene Proteins 0.000 description 1
YSGSDAIMSCVPHG-UHFFFAOYSA-N valyl-methionine Chemical compound CSCCC(C(O)=O)NC(=O)C(N)C(C)C YSGSDAIMSCVPHG-UHFFFAOYSA-N 0.000 description 1
238000012795 verification Methods 0.000 description 1
239000003643 water by type Substances 0.000 description 1

Landscapes

Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

IL9950784A 1983-04-08 1984-04-06 הכנת אימונוגלובולינים בעלי ספציפיותלאנטיגן ידוע בתא פונדקאי מותמר, וקטורים ותאים מותמרים המשתמשים לכך IL99507A (he)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US06/483,457 US4816567A (en)	1983-04-08	1983-04-08	Recombinant immunoglobin preparations
IL7145584A IL71455A (he)	1983-04-08	1984-04-06	שיטה להכנתן של שרשרת אימונוגלובוליןכימריות ותרכובות המכילות אותן

Publications (1)

Publication Number	Publication Date
IL99507A true IL99507A (he)	1995-03-30

Family

ID=26321286

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL9950784A IL99507A (he)	1983-04-08	1984-04-06	הכנת אימונוגלובולינים בעלי ספציפיותלאנטיגן ידוע בתא פונדקאי מותמר, וקטורים ותאים מותמרים המשתמשים לכך

Country Status (1)

Country	Link
IL (1)	IL99507A (he)

1984
- 1984-04-06 IL IL9950784A patent/IL99507A/he not_active IP Right Cessation

Legal Events

Date	Code	Title
1998-10-30	KB	Patent renewed
2002-05-23	KB	Patent renewed
2004-06-20	EXP	Patent expired

Publication	Publication Date	Title
US7923221B1 (en)	2011-04-12	Methods of making antibody heavy and light chains having specificity for a desired antigen
EP0006694B1 (en)	1983-10-12	Method of making a selected protein
JP2527438B2 (ja)	1996-08-21	Ｂ型肝炎ウイルス抗原性を示すポリペプチドをコ−ドするｄｎａ配列
Ott et al.	1991	Cloning and expression in Saccharomyces cerevisiae of a synthetic gene for the type-I trophoblast interferon ovine trophoblast protein-1: purification and antiviral activity
HU196842B (en)	1989-01-30	Process for producing hybrid dna and bonding composition comprising the same
US4565785A (en)	1986-01-21	Recombinant DNA molecule
EP0457875A1 (en)	1991-11-27	Chimeric mouse-human a10 antibody with specificity to a human tumor cell antigen
JPS63233794A (ja)	1988-09-29	ウマガンマーインターフェロン
EP0227110B1 (en)	1991-12-11	Human immunoglobulin g fc region protein and production thereof
JPH02501108A (ja)	1990-04-19	微生物によるヒト副甲状腺ホルモンの生産
EP0404003A2 (en)	1990-12-27	Chimeric mouse-human KM10 antibody with specificity to a human tumor cell antigen
IL99507A (he)	1995-03-30	הכנת אימונוגלובולינים בעלי ספציפיותלאנטיגן ידוע בתא פונדקאי מותמר, וקטורים ותאים מותמרים המשתמשים לכך
CA2283497A1 (en)	1998-09-11	Vectors and methods for expression of mutant proteins
HRP940048A2 (en)	1997-08-31	Process for the preparation of polypeptides having the antigenicity or antigen specificity of hepatitis b viral antigens
KR910700341A (ko)	1991-03-14	합성 인터루킨-6
JPS62228283A (ja)	1987-10-07	Ｄｎａ遺伝子、およびこれを含むプラスミドならびにこのプラスミドを用いる蛋白質の菌体外分泌法